Skip to main content
Log in

Bupropion SR appears to be the most cost-effective smoking cessation therapy compared with nortriptyline and placebo,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Kaper J, van Schayck CP, Severens L.The cost-effectiveness of antidepressants for smoking cessation in patients with COPD. European Respiratory Journal Supplement 28 (Suppl. 50): 801 abstr. 4635, Sep 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bupropion SR appears to be the most cost-effective smoking cessation therapy compared with nortriptyline and placebo,. Pharmacoecon. Outcomes News 514, 8 (2006). https://doi.org/10.2165/00151234-200605140-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605140-00019

Keywords

Navigation